Wanbury gets USFDA approval for 3 new products

Mumbai, Aug 17 (UNI) Wanbury Pharma has got the USFDA (United States Foods and Drugs Authority) approval for manufacture of three new products - Tramadol, Amytriptyline and Paroxetine at its multi product facility in Patalganga.

All the three products would be manufactured along with the company's existing products like Metformin and Salsalate at the plant for which it received the USFDA aproval in 2002.

Director Corporate Finance of the company, Ashok Shinkar, said through a release that ''This USFDA approval strengthens our confidence of remaining a committed API player in the refulated market and our resolve to achieve our goal of Rs 1,000 crore market capitaliation by the year 2009.'' UNI KKD MJ AG1809